Grupo 3: Enfermedades Sistémicas de Base Autoinmune
Código de grupo: 5.03
Tipo de grupo: Consolidado
Descripción del grupo: Enfermedades sistémicas de base autoinmune
Jefe de Grupo: Dr. José María Álvaro-Gracia
Integrantes del grupo | |
---|---|
Investigadores y personal de apoyo |
ÁLVARO-GRACIA | ÁLVARO | JOSÉ MARÍA | Leading Researcher |
CASTREJON | FERNANDEZ | ISABEL | Established Researcher |
DEL RIO | BLASCO | TAMARA | First Stage Researcher |
GONZÁLEZ | FERNÁNDEZ | CARLOS MANUEL | Established Researcher |
GONZALEZ | HERNANDEZ | TERESA | First Stage Researcher |
MOLINA | COLLADA | JUAN | First Stage Researcher |
MARTINEZ | BARRIO | JULIA | Recognised Researcher |
NIETO | GONZALEZ | JUAN CARLOS | Recognised Researcher |
RIVERA | REDONDO | FRANCISCO JAVIER | Established Researcher |
SERRANO | BENAVENTE | BELEN | First Stage Researcher |
Líneas de investigación | |
---|---|
Axis 1: Biological and targeted therapies for rheumatic diseases
L1: Safety and efficacy in biologic and targeted therapies -BIOBADASER L2: Biomarkers of response to methotrexate and JAK inhibitors. Axis 2: Rheumatoid arthritis L1: Early arthritis – REUCARE Axis 3: Systemic autoimmune rheumatic diseases L1: FAST track in giant cell arteritis L2: Biomarkers of activity in scleroderma L3: Remission and discordance in SLE – RELESSER L4: Characterisation of Sjogren’s syndrome Axis 4: Osteoporosis and Bone Metabolism L1: Osteoporosis and mastocytosis Axis 5: Imaging in rheumatology L1: Ultrasonography in large vessel vasculitis Axis 6: Chronic musculoskeletal pain L1. Fibromyalgia and COVID19 |
First decile publications | 2 | 54,8 |
First quartile publications | 6 | 80,0 |
Second quartile publications | 4 | 16,5 |
Third quartile publications | 5 | 17,7 |
Total publications (including those without IF) | 31 | 116,3 |